Table of Contents

company-logo

HighTide Therapeutics, Inc., an investment holding company, engages in the discovery, research and development, and commercialization of multifunctional therapies for the treatment of metabolic and digestive diseases with unmet medical needs. Its lead product candidate is HTD1801, a gut-liver anti-inflammatory metabolic modulator that targets metabolic dysfunction-associated steatohepatitis, type 2 diabetes mellitus, severe hypertriglyceridemia, primary sclerosing cholangitis, and primary biliary cholangitis. The company is also developing HTD4010, a polypeptide drug for the treatment of alcoholic hepatitis; HTD1804 to treat obesity; HTD1805, a multifunctional small molecule drug for the treatment of metabolic diseases; and HTD2802 for the treatment of inflammatory bowel disease. HighTide Therapeutics, Inc. was founded in 2011 and is headquartered in Shenzhen, China.

HighTide Therapeutics Dividend Announcement

• HighTide Therapeutics does not currently offer dividends, we're keeping a close eye on its growth potential and financial developments.
• Stay tuned for updates on HighTide Therapeutics dividend policy and future announcements. In the meantime, explore other dividend-yielding opportunities on our website.

HighTide Therapeutics Dividend History

HighTide Therapeutics Dividend Yield

HighTide Therapeutics current trailing twelve-month (TTM) dividend yield is -%. Interested in purchasing HighTide Therapeutics stock? Use our calculator to estimate your expected dividend yield:

HighTide Therapeutics Financial Ratios

P/E ratio-1.07
PEG ratio-0.01
P/B ratio0.75
ROE-63.33%
Payout ratio0.00%
Current ratio10.12
Quick ratio10.12
Cash Ratio6.68

HighTide Therapeutics Dividend FAQ

Does HighTide Therapeutics stock pay dividends?
HighTide Therapeutics does not currently pay dividends to its shareholders.
Has HighTide Therapeutics ever paid a dividend?
No, HighTide Therapeutics has no a history of paying dividends to its shareholders. HighTide Therapeutics is not known for its dividend payments.
Why doesn't HighTide Therapeutics pay dividends?
There are several potential reasons why HighTide Therapeutics would choose not to pay dividends to their shareholders:

1. Growth opportunities: Companies, especially in fast-growing industries like technology, reinvest earnings into expansion, R&D, or acquisitions to fuel future growth and increase company value.

2. Tax implications: Not paying dividends can reduce the tax burden on shareholders, who may prefer to defer taxes until selling shares and realizing capital gains.

3. Investor preferences: Some investors prefer companies to reinvest profits for higher long-term returns, particularly those seeking capital appreciation over income.

4. Capital allocation priorities: Companies may allocate cash to pay down debt, fund share buybacks, or invest in projects with higher returns than dividends.

5. Market expectations: In certain sectors, like technology, reinvesting profits for growth and innovation is often prioritized over distributing dividends to shareholders.
Will HighTide Therapeutics ever pay a dividend?
The decision for a company to pay dividends depends on various factors including its financial performance, growth prospects, capital allocation priorities, and shareholder preferences. While HighTide Therapeutics has not paid dividends historically and has instead focused on reinvesting its earnings for growth, it's ultimately up to the company's management and board of directors to decide whether to initiate a dividend policy in the future.
Is HighTide Therapeutics a dividend aristocrat?
HighTide Therapeutics is not considered a Dividend Aristocrat. The term "Dividend Aristocrat" is typically used to describe a company in the S&P 500 index that has increased its dividend payouts for at least 25 consecutive years.
Is HighTide Therapeutics a dividend king?
HighTide Therapeutics is not classified as a "Dividend King". A Dividend King is a company that has managed to increase its dividend payouts for 50 consecutive years or more, which is an even more selective group than the Dividend Aristocrats.
Is HighTide Therapeutics a dividend stock?
No, HighTide Therapeutics is not considered a dividend stock. A dividend stock is a stock of a company that regularly pays out dividends to its shareholders.
How to buy HighTide Therapeutics stocks?
To buy HighTide Therapeutics you need a brokerage account. Open an account with a reputable brokerage firm that offers access to the stock market. Consider factors such as fees and account minimums.

Place an order: Use the brokerage's trading platform to place an order to buy HighTide Therapeutics stock.

Remember that buying stocks involves risk, and it's important to carefully consider your investment goals, risk tolerance, and conduct thorough research before making any investment decisions.